Journal of Clinical Densitometry
Volume 12, Issue 4 , Pages 456-460 , October 2009

Phalangeal Quantitative Ultrasound and Bone Mineral Density in Evaluating Cortical Bone Loss: A Study in Postmenopausal Women With Primary Hyperparathyroidism and Subclinical Iatrogenic Hyperthyroidism

Received 1 April 2009 ,Revised 31 July 2009 ,Accepted 2 August 2009.

References 

  1. Silverberg SJ, Shane E, de la Cruz L, et al. Skeletal disease in primary hyperparathyroidism. J Bone Miner Res. 1989;4:283–291
  2. Christiansen P, Steiniche T, Brockstedt H, et al. Primary hyperparathyroidism: iliac crest cortical thickness, structure, and remodelling evaluated by histomorphometric methods. Bone. 1993;14:755–762
  3. Uchiyama T, Tanizawa T, Ito A, et al. Microstructure of the trabecula and cortex of iliac bone in primary hyperparathyroidism patients determined using histomorphometry and node-strut analysis. J Bone Miner Metab. 1999;17:283–288
  4. Eriksen EF. Primary hyperparathyroidism: lessons from bone histomorphometry. J Bone Miner Res. 2002;17(S2):N95–N97
  5. Grimnes G, Emaus N, Joakimsen RM, et al. The relationship between serum TSH and bone mineral density in men and postmenopausal women: the Tromsø study. Thyroid. 2008;18:1147–1155
  6. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008;29:76–131
  7. Földes J, Tarján G, Szathmari M, et al. Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis?. Clin Endocrinol (Oxf). 1993;39:521–527
  8. Tauchmanovà L, Nuzzo V, Del Puente A, et al. Reduced bone mass detected by bone quantitative ultrasonometry and DEXA in pre- and postmenopausal women with endogenous subclinical hyperthyroidism. Maturitas. 2004;15(48):299–306
  9. Glüer CC, Wu CY, Jergas M, et al. Three quantitative ultrasound parameters reflect bone structure. Calcif Tissue Int. 1994;55:46–52
  10. De Terlizzi F, Battista S, Cavani F, et al. Influence of bone tissue density and elasticity on ultrasound propagation: an in vitro study. J Bone Miner Res. 2000;15:2458–2466
  11. Barkmann R, Lüsse S, Stampa B, et al. Assessment of the geometry of human finger phalanges using quantitative ultrasound in vivo. Osteoporos Int. 2000;11:745–755
  12. Montagnani A, Gonnelli S, Cepollaro C, et al. Graphic trace analysis of ultrasound at the phalanges may differentiate between subjects with primary hyperparathyroidism and with osteoporosis: a pilot study. Osteoporos Int. 2002;13:222–227
  13. Camozzi V, Lumachi F, Mantero F, et al. Phalangeal quantitative ultrasound technology and dual energy X-ray densitometry in patients with primary hyperparathyroidism: influence of sex and menopausal status. Osteoporos Int. 2003;14:602–608
  14. Gonnelli S, Montagnani A, Cepollaro C, et al. Quantitative ultrasound and bone mineral density in patients with primary hyperparathyroidism before and after surgical treatment. Osteoporos Int. 2000;11:255–260
  15. Csupor E, Szabolcs I, Ferencz V, et al. Comparison of osteodensitometric and quantitative ultrasound parameters among patients suffering from pseudo-pseudohypoparathyroidism, pseudohypoparathyroidism type I/A and primary hyperparathyroidism. Osteoporos Int. 2006;(Suppl 1):S79–S80
  16. Hans DB, Shepherd JA, Schwartz EN, et al. Peripheral dual-energy X-ray absorptiometry in the management of osteoporosis: the 2007 ISCD Official Position. J Clin Densitom. 2008;11:188–206
  17. Hans D, Downs RW, Duboeuf F, et al. International society for clinical densitometry skeletal sites for osteoporosis diagnosis: the 2005 ISCD official positions. J Clin Densitom. 2006;9:15–21
  18. Krieg MA, Barkmann R, Gonnelli S, et al. Quantitative ultrasound in the management of osteoporosis: the 2007 ISCD official position. J Clin Densitom. 2008;11:163–187
  19. Wüster C, Albanese C, De Aloysio D, et al. Phalangeal osteosonogrammetry study: age-related changes, diagnostic sensitivity, and discrimination power. The Phalangeal Osteosonogrammetry Study Group. J Bone Miner Res. 2000;15:1603–1614
  20. Griffith JF, Genant HK. Bone mass and architecture determination: state of the art. Best Pract Res Clin Endocrinol Metab. 2008;22:737–764
  21. Hans D, Durosier C, Kanis JA, et al. Assessment of the 10-year probability of osteoporotic hip fracture combining clinical risk factors and heel bone ultrasound: the EPISEM prospective cohort of 12,958 elderly women. J Bone Miner Res. 2008;23:1045–1051
  22. Durosier C, Hans D, Krieg MA, et al. Defining risk thresholds for a 10-year probability of hip fracture model that combines clinical risk factors and quantitative ultrasound: results using the EPISEM cohort. J Clin Densitom. 2008;11:397–403
  23. Nanchen D, Cornuz J, Ruffieux C, et al. SEMOF Study Group Combining bone resorption markers and heel quantitative ultrasound to discriminate between fracture cases and controls. Osteoporos Int. 2009;[Epub 31 January 2009]
  24. Alexandersen P, De Terlizzi F, Tankó LB, et al. Comparison of quantitative ultrasound of the phalanges with conventional bone densitometry in healthy postmenopausal women. Osteoporos Int. 2005;16:1071–1078
  25. Camozzi V, Luisetto G, Zangari M, et al. Quantitative ultrasound technology in evaluating bone status and osteoporosis in patients with Cushing's syndrome. Ann N Y Acad Sci. 2007;1117:352–356
  26. Cepollaro C, Gonnelli S, Rottoli P, et al. Bone ultrasonography in glucocorticoid-induced osteoporosis. Osteoporos Int. 2005;16:743–748
  27. Njeh CF, Richards A, Boivin CM, et al. Factors influencing the speed of sound through the proximal phalanges. J Clin Densitom. 1999;2:241–249
  28. Minisola S, Rosso R, Scarda A, et al. Quantitative ultrasound assessment of bone in patients with primary hyperparathyroidism. Calcif Tissue Int. 1995;56:526–528
  29. Ingle BM, Thomas WEG, Eastell R. Differential effects of primary hyperparathyroidism on ultrasound properties of bone. Osteoporos Int. 2002;13:572–578

PII: S1094-6950(09)00226-1

doi: 10.1016/j.jocd.2009.08.002

Journal of Clinical Densitometry
Volume 12, Issue 4 , Pages 456-460 , October 2009